OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis
Zhicheng Gong, Aicun Li, Jian‐cheng Ding, et al.
Advanced Science (2021) Vol. 8, Iss. 15
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Targeting Breast Cancer Stem Cells
Lu Zhang, Wen‐Ming Chen, Suling Liu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 552-570
Open Access | Times Cited: 112

The ubiquitin–proteasome system in breast cancer
Dianwen Han, Lijuan Wang, Shan Jiang, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 8, pp. 599-621
Closed Access | Times Cited: 46

METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions
Yuanpei Li, Xiaoniu He, Lu Xiao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 62

OTUD7B deubiquitinates SQSTM1/p62 and promotes IRF3 degradation to regulate antiviral immunity
Weihong Xie, Shuo Tian, Jiahui Yang, et al.
Autophagy (2022) Vol. 18, Iss. 10, pp. 2288-2302
Open Access | Times Cited: 40

Role of K63-linked ubiquitination in cancer
Liangzi Cao, Xiaofang Liu, Bowen Zheng, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 35

Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis
Zhitao Han, Qi Jia, Jilei Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 20

AtomNet-Aided OTUD7B Inhibitor Discovery and Validation
Jianfeng Chen, Derek L. Bolhuis, Christian Laggner, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 517-517
Open Access | Times Cited: 14

LSD1 in drug discovery: From biological function to clinical application
Huimin Liu, Ying Zhou, He‐Xiang Chen, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 833-866
Closed Access | Times Cited: 14

Strategies that regulate LSD1 for novel therapeutics
Meng Li, Mengge Dai, Bingchuan Cheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 4, pp. 1494-1507
Open Access | Times Cited: 5

A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance
Guan‐Jun Yang, Yanjun Liu, Lijian Ding, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20

OTUB1 inhibits breast cancer by non‐canonically stabilizing CCN6
Ying Zhao, Jing Ruan, Zhongding Li, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 12

OTUD7B is a new deubiquitinase targeting p53
Chaopu Ding, Leixi Cao, Ruijie Wang, et al.
Theranostics (2025) Vol. 15, Iss. 6, pp. 2121-2138
Open Access

LSD1 is a targetable vulnerability in gastric cancer harboring TP53 frameshift mutations
Suzeng Wang, Chunyu Yang, Junhui Tang, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access

Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks
Sepideh Mirzaei, Bijan Ranjbar, Saeed Hesami Tackallou, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154676-154676
Closed Access | Times Cited: 10

Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanoma
Aicun Li, Zhicheng Gong, Yuhan Long, et al.
Developmental Cell (2025)
Closed Access

OTUD7B controls oxLDL uptake by stabilizing Lox-1 in THP-1 and U937 cells
Yanbiao Rao, Feng Li, Chao Wan, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2025), pp. 159618-159618
Closed Access

The role of lncRNAs and exosomal lncRNAs in cancer metastasis
Yutong Zhang, Lijuan Zhao, Ya‐Ping Bi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115207-115207
Open Access | Times Cited: 8

E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC
Feiyu Tang, Can Lu, Xiang He, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113477-113477
Open Access | Times Cited: 8

OTUD7B knockdown inhibits the proliferation and stemness of breast cancer cells by destabilizing FOXM1
Hebing Wang, Sumei Han, Jian Xiao, et al.
Oncology Letters (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 3

RNF20 contributes to epigenetic immunosuppression through CDK9-dependent LSD1 stabilization
Bo Dong, Xinzhao Wang, Xiang Song, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 7
Open Access | Times Cited: 3

OTUD7B (Cezanne) ameliorates fibrosis after myocardial infarction via FAK-ERK/P38 MAPK signaling pathway
Jiayan Zhang, Yafang Zha, Yuheng Jiao, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 724, pp. 109266-109266
Closed Access | Times Cited: 14

EXOSC8 promotes colorectal cancer tumorigenesis via regulating ribosome biogenesis-related processes
Kaisa Cui, Liang Gong, Han Zhang, et al.
Oncogene (2022) Vol. 41, Iss. 50, pp. 5397-5410
Closed Access | Times Cited: 11

Page 1 - Next Page

Scroll to top